A number of acute wasting conditions are associated with an upregulation of the
ubiquitin-
proteasome system in skeletal muscle.
Eicosapentaenoic acid (EPA) is effective in attenuating the increased
protein catabolism in muscle in
cancer cachexia, possibly due to inhibition of 15-hydroxyeicosatetraenoic
acid (15-HETE) formation. To determine if a similar pathway is involved in other catabolic conditions, the effect of EPA on
muscle protein degradation and activation of the
ubiquitin-
proteasome pathway has been determined during acute fasting in mice. When compared with a vehicle control group (
olive oil) there was a significant decrease in proteolysis of the soleus muscles of mice treated with EPA after
starvation for 24 h, together with an attenuation of the
proteasome "chymotryptic-like"
enzyme activity and the induction of the expression of the
20S proteasome alpha-subunits, the 19S regulator and p42, an
ATPase subunit of the 19S regulator in gastrocnemius muscle, and the
ubiquitin-conjugating enzyme E2(14k). The effect was not shown with the related (n-3)
fatty acid docosahexaenoic acid (DHA) or with
linoleic acid. However, 2,3,5-trimethyl-6-(3-pyridylmethyl)1,4-benzoquinone (CV-6504), an inhibitor of 5-, 12- and 15-lipoxygenases also attenuated
muscle protein catabolism,
proteasome "chymotryptic-like"
enzyme activity and expression of
proteasome 20S alpha-subunits in soleus muscles from acute fasted mice. These results suggest that
protein catabolism in
starvation and
cancer cachexia is mediated through a common pathway, which is inhibited by EPA and is likely to involve a
lipoxygenase metabolite as a signal transducer.